JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $119,000 | -90.6% | 39,339 | -76.8% | 0.00% | -100.0% |
| Q3 2021 | $1,261,000 | -26.3% | 169,686 | -32.5% | 0.01% | -37.5% |
| Q2 2021 | $1,710,000 | +75.7% | 251,478 | +165.4% | 0.01% | +100.0% |
| Q1 2021 | $973,000 | +67.2% | 94,739 | +12.3% | 0.00% | 0.0% |
| Q2 2020 | $582,000 | -52.2% | 84,369 | -67.1% | 0.00% | -66.7% |
| Q1 2020 | $1,217,000 | -70.6% | 256,139 | -45.9% | 0.01% | -57.1% |
| Q4 2019 | $4,134,000 | +4597.7% | 473,565 | +1721.5% | 0.03% | +2700.0% |
| Q4 2018 | $88,000 | – | 25,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 9,200,349 | $64,402,000 | 44.86% |
| TRV GP III, LLC | 3,048,780 | $21,342,000 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 406,665 | $2,847,000 | 1.65% |
| Sofinnova Investments, Inc. | 925,280 | $6,477,000 | 0.39% |
| Omega Fund Management, LLC | 334,965 | $2,345,000 | 0.35% |
| Yorktown Management & Research Co Inc | 49,200 | $344,000 | 0.31% |
| Woodline Partners LP | 940,902 | $6,586,000 | 0.18% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 51,000 | $357,000 | 0.09% |
| HORIZON FINANCIAL SERVICES, LLC | 12,005 | $84,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 26,893 | $188,000 | 0.06% |